Micronutrient of benefit in heart failure patients
Professor Rosenfeldt with a patient
Optimal therapy of heart failure (HF) is the goal every medical practitioner is aiming for, and routes to it are diverse. Professor Frank Rosenfeldt of the Department of Surgery and a group of collaborators have investigated the effect of a micronutrient called Coenzyme Q10 with a group of 420 clinical trial HF participants. It was a randomised, controlled, multicentre trial. Their finding was that the intervention group using Coenzyme Q10 as adjunctive treatment did better than the placebo group.